CAFC Updates

Iridescent sued AT&T and Ericsson for infringement of U.S. Patent No. 8,036,119 relating to systems and methods of network communication that provide guaranteed...

Genetic Veterinary Sciences sued the University of Bern and LABOKLIN (the University’s exclusive licensee) seeking a declaratory judgment that claims of the...

Hospira and Dr. Reddy’s appeal from two judgments of the district court in two infringement suits brought by Eli Lilly under the Hatch-Waxman...

ATEN appeals the District Court’s denial of judgment as a matter of law (“JMOL”), which declined to overturn the jury’s findings that the...

Uniclass and others appeal the District Court’s order denying their motion for attorney fees. Appellants argue that the district court erred in...

After VirnetX sued Apple in district court alleging infringement of U.S. Patent Nos. 7,418,504 and 7,921,211 (both relating to systems and methods for...

When Hylete’s design mark for a stylized letter “H” for athletic apparel, namely, shirts, pants, shorts, jackets, footwear, hats and caps was published...

U.S. Bancorp and its affiliate Elavon, Inc. (collectively, U.S. Bank) appeal the district court’s order denying U.S. Bank’s motion for summary judgment that...

The Coalition for Affordable Drugs (“CFAD”) filed a petition for inter partes review (“IPR”) challenging the validity of all of the claims of Celgene’s U.S....

Coherus filed an abbreviated Biologic License Application (“aBLA”) seeking FDA approval to market a biosimilar version of Amgen’s pegfilgrastim product Neulasta, a recombinant...